Intra-Cellular Therapies Inc. buy Vassago1
Start price
16.12.21
/
50%
€32.60
Target price
16.12.22
-
Performance (%)
38.19%
End price
25.12.21
€45.05
Summary
This prediction ended on 25.12.21 with a price of €45.05. The BUY prediction by Vassago1 for Intra-Cellular Therapies Inc. saw massive gains of 38.19%. Vassago1 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intra-Cellular Therapies Inc. | - | - | - | - |
| iShares Core DAX® | 2,55 % | 0,56 % | 14,14 % | 49,14 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % | 30,37 % | 82,05 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % | 49,37 % | 60,62 % |
| iShares S&P 500 | 1,93 % | -0,51 % | 24,26 % | 59,66 % |
According to Vassago1 what are the pros and cons of Intra-Cellular Therapies Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Vassago1 for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Buy Intra-Cellular Therapies Inc.